Medtep Competitors and Similar CompaniesClear all
Medtep's competitors and similar companies include Durect and BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |||
Founding Date | Founding Date 2011 | Founding Date N/A | Founding Date 1948 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations Cupertino, US HQ | |
Employees | Employees 1 | Employees 902% increase | Employees 650 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2m (FY, 2024) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $78k (FY, 2024) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit $2m (FY, 2024) | Gross profit £510.3m (FY, 2019) |
Net income | Net income N/A | Net income ($8.3m) (FY, 2024) | Net income £88.3m (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 2.2m | Total funding raised $ 20m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company